Literature DB >> 17376917

Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

Samuel A Williams1, Hakju Kwon, Lin-Feng Chen, Warner C Greene.   

Abstract

Cells harboring infectious, but transcriptionally latent, human immunodeficiency virus type 1 (HIV-1) proviruses currently pose an insurmountable barrier to viral eradication in infected patients. To better understand the molecular basis for HIV-1 latency, we used the J-Lat model of postintegration HIV-1 latency to assess the kinetic relationship between the induction of NF-kappaB and the activation of latent HIV-1 gene expression. Chromatin immunoprecipitation analyses revealed an oscillating pattern of RelA recruitment to the HIV-1 long terminal repeat (LTR) during continuous tumor necrosis factor alpha (TNF-alpha) stimulation. RNA polymerase II (Pol II) recruitment to the HIV-1 LTR closely mirrored RelA binding. Transient stimulation of cells with TNF-alpha for 15 min induced only a single round of RelA and RNA Pol II binding and failed to induce robust expression of latent HIV-1. Efficient formation of elongated HIV-1 transcripts required sustained induction by NF-kappaB, which promoted de novo synthesis of Tat. Cyclin-dependent kinase 9 (CDK9) and serine-2-phosphorylated RNA Pol II were rapidly recruited to the HIV-1 LTR after NF-kappaB induction; however, these elongating polymerase complexes were progressively dephosphorylated in the absence of Tat. Okadaic acid promoted sustained serine-2 phosphorylation of the C-terminal domain of RNA Pol II and stimulated efficient transcriptional elongation and HIV-1 expression in the absence of Tat. These findings underscore important differences between NF-kappaB and Tat stimulation of RNA Pol II elongation. While NF-kappaB binding to the HIV-1 LTR induces serial waves of efficient RNA Pol II initiation, elongation is impaired by the action of an okadaic acid-sensitive phosphatase that dephosphorylates the C-terminal domain of RNA Pol II. Conversely, the action of this phosphatase is overcome in the presence of Tat, promoting very efficient RNA Pol II elongation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376917      PMCID: PMC1900291          DOI: 10.1128/JVI.02074-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.

Authors:  S Emiliani; C Van Lint; W Fischle; P Paras; M Ott; J Brady; E Verdin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.

Authors:  Young Kyeung Kim; Cyril F Bourgeois; Richard Pearson; Mudit Tyagi; Michelle J West; Julian Wong; Shwu-Yuan Wu; Cheng-Ming Chiang; Jonathan Karn
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

3.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

4.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Authors:  Y Zhu; T Pe'ery; J Peng; Y Ramanathan; N Marshall; T Marshall; B Amendt; M B Mathews; D H Price
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

5.  Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.

Authors:  C A Parada; R G Roeder
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

6.  A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.

Authors:  J A DiDonato; M Hayakawa; D M Rothwarf; E Zandi; M Karin
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

7.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.

Authors:  C H Herrmann; A P Rice
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Achieving stability of lipopolysaccharide-induced NF-kappaB activation.

Authors:  Markus W Covert; Thomas H Leung; Jahlionais E Gaston; David Baltimore
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

9.  Stimulus specificity of gene expression programs determined by temporal control of IKK activity.

Authors:  Shannon L Werner; Derren Barken; Alexander Hoffmann
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

10.  NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

Authors:  Samuel A Williams; Lin-Feng Chen; Hakju Kwon; Carmen M Ruiz-Jarabo; Eric Verdin; Warner C Greene
Journal:  EMBO J       Date:  2005-12-01       Impact factor: 11.598

View more
  81 in total

1.  Functional nuclear topography of transcriptionally inducible extra-chromosomal transgene clusters.

Authors:  Manja Meggendorfer; Claudia Weierich; Horst Wolff; Ruth Brack-Werner; Thomas Cremer
Journal:  Chromosome Res       Date:  2010-06-08       Impact factor: 5.239

2.  Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.

Authors:  Frank Wolschendorf; Alexandra Duverger; Jennifer Jones; Frederic H Wagner; Jason Huff; William H Benjamin; Michael S Saag; Michael Niederweis; Olaf Kutsch
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion.

Authors:  Matjaz Barboric; Tina Lenasi
Journal:  Nat Struct Mol Biol       Date:  2010-08       Impact factor: 15.369

4.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  CRISPR-mediated Activation of Latent HIV-1 Expression.

Authors:  Prajit Limsirichai; Thomas Gaj; David V Schaffer
Journal:  Mol Ther       Date:  2015-11-26       Impact factor: 11.454

Review 6.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

7.  CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency.

Authors:  Mudit Tyagi; Jonathan Karn
Journal:  EMBO J       Date:  2007-11-15       Impact factor: 11.598

8.  High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor.

Authors:  Sofiya Micheva-Viteva; Yoshifumi Kobayashi; Leonard C Edelstein; Annmarie L Pacchia; Hui-Ling Rose Lee; Jason D Graci; Jamie Breslin; Bradley D Phelan; Leia K Miller; Joseph M Colacino; Zhengxian Gu; Yacov Ron; Stuart W Peltz; Joseph P Dougherty
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

9.  Transcriptional burst frequency and burst size are equally modulated across the human genome.

Authors:  Roy D Dar; Brandon S Razooky; Abhyudai Singh; Thomas V Trimeloni; James M McCollum; Chris D Cox; Michael L Simpson; Leor S Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

10.  Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.

Authors:  Richard Pearson; Young Kyeung Kim; Joseph Hokello; Kara Lassen; Julia Friedman; Mudit Tyagi; Jonathan Karn
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.